Cocrystal Pharma (COCP) Financials

$1.18

$0.05 (4.42%)

As on 08-Sep-2026 16:00EDT

Market cap

$22 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

20.6

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.33	--	--	--	--	5.43
Cost of Revenue	-0.35	5.06	12.54	15.17	12.39	8.79
Gross Profit	0.68	-5.06	-12.54	-15.17	-12.39	-8.79
Operating Expenses	10.79	3.96	5.34	3.39	26.44	5.43
Operating Profit (EBIT)	-10.11	-9.02	-17.88	-18.56	-38.83	-14.22
Other Income	--	--	--	--	--	--
Profit before Tax	-9.94	-8.83	-17.50	-17.98	-38.84	-14.19
Provision for Tax	--	--	-17.50	0.00	0.01	0.00
Profit after Tax (Net Income)	-9.94	-8.83	-17.50	-17.98	-38.84	-14.19
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-38.84	-14.19

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	1.04	6.33	9.52	26.38	39.57	77.55
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.99	1.17	1.51	1.61	0.06	0.30
Current Liabilities	2.62	2.21	2.43	3.26	1.22	1.55
Total Liabilities	7.27	9.71	13.46	31.26	40.84	79.39

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	1.41	1.58	1.88	2.17	0.66	20.07
Current Assets	3.24	8.13	11.58	29.09	40.18	59.32
Total Assets	7.27	9.71	13.46	31.26	40.84	79.39
Total Debt*	1.34	1.51	1.81	1.85	0.30	0.53
Net Current Assets	0.62	5.92	9.15	25.83	38.96	57.78

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-8.19	-16.49	-14.67	-21.44	-12.72
Cash Flow from Investing Activities	--	-0.01	-0.01	-0.12	-0.07	-0.05
Cash from Financing Activities	--	5.37	--	3.99	-0.03	38.47
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.80	-0.78	-1.72	-1.77	-4.77	-1.95
Cash EPS ($)	--	-0.75	-1.68	-1.73	-4.72	-1.90
Adjusted Book Value ($)	--	0.56	0.94	2.59	4.86	10.69
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.73	-1.62	-1.44	-2.63	-1.75
Free Cash Flow per Share ($)	--	-0.73	-1.62	-1.45	-2.64	-1.76

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-92.16	-88.48	-52.82	-65.86	-21.63
ROE (%)	-269.51	-111.40	-97.50	-54.54	-66.32	-21.81
ROA (%)	-112.93	-76.23	-78.29	-49.89	-64.60	-21.23
EBIT Margin (%)	-3,011.52	--	--	--	--	-261.30
Net Margin (%)	-3,011.52	--	--	--	--	-261.38
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	142.65	--	--	--	-1.00	1.69
EBIT Growth (%)	20.88	49.55	17.27	-16.66	-27.90	-47.93
Net Profit Growth (%)	20.88	49.55	2.67	53.69	-173.79	-47.03
EPS Growth (%)	35.40	0.55	0.03	0.63	-1.44	0.03
Book Value Growth (%)	-85.55	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.25	-1.17	-0.97	-0.41	-0.33
Price / Book Value	20.57	1.75	2.16	0.66	0.40	0.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.66	-0.65	-0.72	0.33	1.17	3.82
Close Price ($)	1.05	0.98	2.02	1.72	1.95	7.80
High Price ($)	2.67	2.67	3.26	3.29	8.88	41.52
Low Price ($)	0.86	0.90	1.33	1.38	1.74	7.68
Market Cap ($ Cr)	21.77	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.24	0.19	0.07	0.01	0.01
Short term debt to equity ratio	0.34	0.05	0.03	0.01	0.01	0.00
Current Ratio	1.24	3.68	4.77	8.92	33.04	38.40
Quick Ratio	1.24	--	--	--	32.98	--
Interest Coverage	--	--	--	--	-9,068.50	-3,545.25

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	223.03	--	--	--	--	--
Asset Turnover	0.04	--	--	--	--	0.08
Receivable days	--	--	--	--	--	18.71
Inventory Days	--	--	--	1.81	2.21	2.08
Payable days	--	87.86	40.26	22.10	17.57	25.65
Cash Conversion Cycle	--	--	--	--	--	-4.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.